| Serial Number | 98449022 |
| Word Mark | VASCUDYNE |
| Filing Date | Thursday, March 14, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, February 3, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 3, 2026 |
| Goods and Services | (Based on Intent To Use) Agents for medical purposes, namely, biotechnologically engineered tissue products in the nature of cells and tissue cell sheets for the treatment of cardiac disease and conditions; biological tissue implants comprising living tissue for medical and cosmetic purposes; biotechnologically engineered tissue products, namely, cells and tissue cell sheets for medical use; regenerative biological tissue sheets for medical purposes; surgical implants comprised of living tissue; transcatheter implants comprised of living tissue; biological material, namely, tissue sheets for the treatment of wounds; biological material, namely, cells and tissue cell sheets for the treatment of damaged skin and tissue; biological tissue grafts; vascular grafts |
| Goods and Services | (Based on Intent To Use) Surgical apparatus; surgical apparatus for medical or veterinary use; medical and surgical apparatus, namely, implantable artificial cardiac valves; medical apparatus for use in percutaneous and endovascular procedures; medical apparatus for use in cardiovascular procedures; medical apparatus for treating cardiovascular disease; cardiac valves for surgical prostheses; prostheses for cardiovascular systems, namely, for the heart and heart valves; artificial cardiac valves for implantation as part of the cardiovascular system; subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; valve implants consisting of artificial materials for implementation as part of the cardiovascular system; medical devices for use in treating cardiac disease; replacement tissue valves being implants comprising artificial and natural, non-living materials for the human heart; catheters |
| Goods and Services | (Based on Use in Commerce) Scientific research and development; biomedical research and development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, August 11, 2020 |
| First Use In Commerce Date | Tuesday, August 11, 2020 |
| Party Name | Vascudyne, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | St. Paul, MN 55107 |
| Party Name | Vascudyne, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | St. Paul, MN 55107 |
| Event Date | Event Description |
| Thursday, March 14, 2024 | NEW APPLICATION ENTERED |
| Tuesday, August 6, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 24, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 1, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 1, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 2, 2025 | SUSPENSION LETTER WRITTEN |
| Thursday, January 2, 2025 | LETTER OF SUSPENSION E-MAILED |
| Thursday, January 2, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Saturday, July 5, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, January 6, 2026 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, January 6, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 9, 2026 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, January 28, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 3, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 3, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |